Idogen Overview
- Founded
- 2008

- Status
- Public
- Employees
- 9

- Stock Symbol
- IDOGEN

- Share Price
- $0.36
- (As of Tuesday Closing)
Idogen General Information
Description
Idogen AB is a Swedish biotech company engaged in developing tolerogenic cell therapies to prevent biological drugs, transplanted or body cells or tissues from being attacked by the patient's immune system. Its product IDO 8, treats patients with severe hemorrhagic disease.
Contact Information
- Medicon Village
- Scheelevagen 2
- 223 81 Lund
- Sweden
Idogen Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.36 | $0.37 | $0.34 - $0.84 | $6.6M | 18.2M | 79.9K | -$0.36 |
Idogen Financials Summary
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
---|---|---|---|---|
EV | 1,449 | 749 | 773 | 5,484 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (2,666) | (2,833) | (3,062) | (2,486) |
Net Income | (2,865) | (3,457) | (3,176) | (2,495) |
Total Assets | 3,665 | 3,336 | 7,974 | 5,397 |
Total Debt | 0 | 0 | 0 | 0 |
Idogen Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Idogen‘s full profile, request access.
Request a free trialIdogen Executive Team (11)
Idogen Board Members (2)
Name | Representing | Role | Since |
---|---|---|---|
0000 0000000 | Self | Co-Founder, Advisor & Board Member | 000 0000 |
000000 Ø000 | Ventac Partners | Board Member | 000 0000 |
Idogen Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIdogen Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Idogen‘s full profile, request access.
Request a free trial